넳 넲

R&D

R&D

Cobimetinib

Tinibs

Oncology
Futibatinib
Fedratinib
Momeltonib
Pemigatinib
Olutasidenib
Quizartinib
Ruxolitinib
Regorafenib
Talazoparib
Trametinib
Upadacitinib
끸
Verification Code
Submit
SHENZHEN HAORUI PHARMATECH CO., LTD.

Address: RM503, Wanhai Building B, Nanhai Avenue Nanshan District,Shenzhen 518067 P.R. China.

 

Tel: (86) 755-82960263 (For All) 

 

Web: www.haorui.com

 

Email: info@haorui.com